Pfizer, BioNTech seek COVID vaccine authorization for kids
The two pharmaceuticals said their submission is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.
The two pharmaceuticals said their submission is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.